{"id":5797,"date":"2016-02-19T12:41:00","date_gmt":"2016-02-19T12:41:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/dear-fda-daraprim-website-lacks\/"},"modified":"2019-02-21T01:15:13","modified_gmt":"2019-02-21T01:15:13","slug":"dear-fda-daraprim-website-lacks","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/","title":{"rendered":"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About!"},"content":{"rendered":"<table cellpadding=\"0\" cellspacing=\"0\" class=\"tr-caption-container\" style=\"float: left; margin-right: 1em; text-align: left;\">\n<tbody>\n<tr>\n<td style=\"text-align: center;\"><a href=\"https:\/\/4.bp.blogspot.com\/-qaz1-VVag1k\/Vsb2m_b75lI\/AAAAAAAAIjE\/oNlx9vGD5ZM\/s1600\/DaraprimHPsm.jpg\" imageanchor=\"1\" style=\"clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;\"><img loading=\"lazy\" decoding=\"async\" border=\"0\" height=\"640\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/02\/DaraprimHPsm.jpg\" width=\"196\" \/><\/a><\/td>\n<\/tr>\n<tr>\n<td class=\"tr-caption\" style=\"text-align: center;\">Click on image for an enlarged view.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>(This post was updated on 20-Feb-2016.)<\/p>\n<p>This morning, I was reading a story in MM&amp;M about the testimony of Turing Pharmaceuticals chief commercial officer Nancy Retzlaff during a recent House hearing on drug pricing, where she attempted to justify the 5,000% price increase on the firm&#8217;s toxoplasmosis treatment Daraprim.<\/p>\n<p>Retzlaff &#8220;defended the dramatic hike in part by noting that the drugmaker provides access through patient assistance programs (PAPs)&#8221; (read &#8220;<a href=\"http:\/\/sco.lt\/5BDUeX\">Turing Testimony Changes Perception of #Pharma Patient Assistance Programs<\/a>&#8220;).<\/p>\n<p>I decided to check out Turing&#8217;s PAP by visiting www.turingpharma.com where I clicked on the &#8220;PRODUCTS&#8221; tab, then &#8220;Daraprim.&#8221; I was taken to the <a href=\"http:\/\/www.daraprimdirect.com\/patients\">page<\/a> shown on the left (http:\/\/www.daraprimdirect.com\/patients).<\/p>\n<p>Notice anything unusual?<\/p>\n<p><a name='more'><\/a>The page does not include enough Important Safety Information (ISI), in my opinion. The only side effect mentioned is this:<\/p>\n<p>&#8220;DARAPRIM may cause folate deficiency which can lead to blood toxicity.&#8221; This is not very helpful for patients.<\/p>\n<p>I went to WebMD (<a href=\"http:\/\/www.webmd.com\/drugs\/2\/drug-634\/daraprim-oral\/details#side-effects\">here<\/a>) to read this important list of side effects that patients can recognize: <\/p>\n<p>&#8220;Tell your doctor right away if any of these symptoms occur: easy bruising\/bleeding, signs of serious infection (such as high fever, severe chills, persistent sore throat), signs of low red blood cell count (such as severe tiredness, pale lips\/nails\/skin, fast heartbeat\/breathing with usual activities), swollen\/painful tongue.&#8221;<\/p>\n<p>I am not sure this warrants a Warning Letter from the FDA, but I notified them via OPDP&#8217;s Bad Ad program. Time will tell. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Click on image for an enlarged view. (This post was updated on 20-Feb-2016.) This morning, I was reading a story in MM&amp;M about the testimony of Turing Pharmaceuticals chief commercial officer Nancy Retzlaff during a recent House hearing on drug pricing, where she attempted to justify the 5,000% price increase on the firm&#8217;s toxoplasmosis treatment [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":12108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[293,104,44,294,247,295],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About! - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About! - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Click on image for an enlarged view. (This post was updated on 20-Feb-2016.) This morning, I was reading a story in MM&amp;M about the testimony of Turing Pharmaceuticals chief commercial officer Nancy Retzlaff during a recent House hearing on drug pricing, where she attempted to justify the 5,000% price increase on the firm&#8217;s toxoplasmosis treatment [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-19T12:41:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:15:13+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/02\/DaraprimHPsm.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"200\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/\",\"name\":\"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About! - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2016-02-19T12:41:00+00:00\",\"dateModified\":\"2019-02-21T01:15:13+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About!\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About! - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/","og_locale":"en_US","og_type":"article","og_title":"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About! - Pharma Marketing Network","og_description":"Click on image for an enlarged view. (This post was updated on 20-Feb-2016.) This morning, I was reading a story in MM&amp;M about the testimony of Turing Pharmaceuticals chief commercial officer Nancy Retzlaff during a recent House hearing on drug pricing, where she attempted to justify the 5,000% price increase on the firm&#8217;s toxoplasmosis treatment [&hellip;]","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/","og_site_name":"Pharma Marketing Network","article_published_time":"2016-02-19T12:41:00+00:00","article_modified_time":"2019-02-21T01:15:13+00:00","og_image":[{"width":200,"height":640,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/02\/DaraprimHPsm.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/","name":"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About! - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2016-02-19T12:41:00+00:00","dateModified":"2019-02-21T01:15:13+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/dear-fda-daraprim-website-lacks\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"Dear FDA: The Daraprim Website Lacks Some Important Safety Information Patients Should Know About!"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/5797"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=5797"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/5797\/revisions"}],"predecessor-version":[{"id":12109,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/5797\/revisions\/12109"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/12108"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=5797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=5797"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=5797"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=5797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}